Anavex Life Sciences Corp (AVXL)

[falconer66a]

SAVA and ANVS. Why?

This, of course, is the iHub AVXL message board. The best online compendium of Anavex information, just in front of Anavex’s recent update presentation: http://www.anavex.com/wp-content/uploads/2021/07/Anavex-Presentation-July-2021.pdf

To be pondered are the frequent postings laying out (to a minor degree) information on ANVS, SAVA, and a few other equities. Why are those so frequently mentioned on this board? Please tell: are the FDA (Food and Drug Administration) or the Australian Therapeutic Goods Administration (TGA) constrained to approve only a single drug for the CNS (central nervous system) diseases in the Anavex pipeline; Rett syndrome, Parkinson’s disease dementia, or Alzheimer’s disease? How, in any way, does the consideration for drug use of the products of other pharmaceuticals affect or disqualify in any way a future application of blarcamesine by Anavex Life Sciences Corp?

Fact is, the FDA will approve blarcamesine based solely on its clinical results which, based upon all of the pre- and early clinical data, and efficacious MOA, mechanism of action, will be exceptionally good. When they get Anavex’s New Drug Application (FDA), there will be no information presented or considered on any other new drug owned by SAVA, ANVS, or any other company. To get a new drug approved it must either equal or exceed the efficacies of any existing drugs. For Alzheimer’s, there are but a few; all of which provide only the slightest therapeutic efficacy. Blarcamesine has no competition; its therapeutic outcomes for all three targeted CNS diseases will greatly exceed both the existing and in-trial drugs of any other company.

So, why the awkwardly imposing discussions of matters SAVA, etc. on this board? They are utterly irrelevant. They belong on their own message boards. Usefully, I simply skip or delete any such postings I’m burdened with on this otherwise information-dense message board. The Delete key on my keyboard functions wonderfully.

Of course, some are interested in the pharmaceuticals mentioned on this board solely for short-term trading purposes. Who’s going to make a buck this week on any of the several pharmas that appear here? For those readers, my best wishes. Utterly irrelevant to my goals; to make a very profitable long-term investment (not a trading vehicle). I’ll measure my success at the end of 2023—then continue to retain my AVXL position. I don’t anticipate taking any of my profits (share sales) for many years, if ever. I’m looking for two things from my AVXL position: eventually, rewarding dividends, and, then, dispersal of my position to my estate benefactors upon my demise. That’s all “long term.” I disregard the short-term, day-trading stuff; of no use for me. I’m an investor, not a trader.

Best wishes for all.